Basepoint Wealth’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$233K Buy
796
+3
+0.4% +$986 0.13% 93
2025
Q4
$278K Buy
793
+23
+3% +$7.77K 0.17% 76
2025
Q3
$249K Sell
770
-132
-15% -$41.1K 0.18% 86
2025
Q2
$351K Sell
902
-13
-1% -$5.23K 0.27% 70
2025
Q1
$398K Sell
915
-33
-3% -$13.2K 0.31% 62
2024
Q4
$350K Sell
948
-44
-4% -$18.4K 0.28% 70
2024
Q3
$516K Buy
992
+17
+2% +$9.08K 0.38% 60
2024
Q2
$528K Sell
975
-45
-4% -$23.8K 0.42% 58
2024
Q1
$529K Sell
1,020
-4
-0.4% -$1.99K 0.4% 62
2023
Q4
$483K Hold
1,024
0.39% 65
2023
Q3
$446K Buy
1,024
+32
+3% +$14.5K 0.36% 64
2023
Q2
$441K Sell
992
-46
-4% -$21.2K 0.36% 64
2023
Q1
$477K Sell
1,038
-11
-1% -$5.24K 0.4% 56
2022
Q4
$538K Sell
1,049
-97
-8% -$49.3K 0.48% 53
2022
Q3
$521K Sell
1,146
-240
-17% -$115K 0.56% 47
2022
Q2
$669K Sell
1,386
-444
-24% -$220K 0.7% 34
2022
Q1
$899K Sell
1,830
-142
-7% -$64.9K 0.83% 22
2021
Q4
$914K Buy
+1,972
New +$830K 0.9% 23

Other funds holding ELV

Basepoint Wealth's ELV Position: Q1 2026 in Review

Basepoint Wealth increased its Elevance Health (ELV) stake by 0.38% in Q1 2026, buying an estimated $986 and bringing the position to 796 shares worth $233K. The position accounts for 0.13% of the portfolio, ranked #93.

Basepoint Wealth first reported a position in ELV in Q4 2021 and has held it in 18 quarters since. The position peaked at $914K in Q4 2021. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Basepoint Wealth held 796 shares of Elevance Health worth $233K as of Q1 2026.
  • Basepoint Wealth bought 3 Elevance Health shares in Q1 2026, an estimated $986.
  • Elevance Health made up 0.13% of Basepoint Wealth's portfolio in Q1 2026, its #93 holding.
  • Basepoint Wealth first reported a position in Elevance Health in Q4 2021 and has held it in 18 quarters since.
  • Basepoint Wealth's Elevance Health position peaked at $914K in Q4 2021.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Basepoint Wealth's 13F filing for Q1 2026, filed 7 May 2026.